153 related articles for article (PubMed ID: 33443338)
1. An Assessment of the Completeness and Timeliness of the Israel National Cancer Registry.
Moore E; Silverman BG; Fishler Y; Ben-Adiva E; Davidov O; Dichtiar R; Edri H; Zatlawi M; Keinan-Boker L
Isr Med Assoc J; 2021 Jan; 23(1):23-27. PubMed ID: 33443338
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
3. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.
Zippin C; Lum D; Hankey BF
Cancer; 1995 Dec; 76(11):2343-50. PubMed ID: 8635041
[TBL] [Abstract][Full Text] [Related]
4. Surveillance Evaluation of the National Cancer Registry in Sabah, Malaysia.
Jeffree SM; Mihat O; Lukman KA; Ibrahim MY; Kamaludin F; Hassan MR; Kaur N; Myint T
Asian Pac J Cancer Prev; 2016; 17(7):3123-9. PubMed ID: 27509940
[TBL] [Abstract][Full Text] [Related]
5. The completeness and accuracy of the Norwegian Female Incontinence Registry.
Dyrkorn OA; Staff AC; Kulseng-Hanssen S; Dimoski T; Svenningsen R
Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1618-1625. PubMed ID: 32640493
[TBL] [Abstract][Full Text] [Related]
6. Completeness and timeliness: Cancer registries could/should improve their performance.
Zanetti R; Schmidtmann I; Sacchetto L; Binder-Foucard F; Bordoni A; Coza D; Ferretti S; Galceran J; Gavin A; Larranaga N; Robinson D; Tryggvadottir L; Van Eycken E; Zadnik V; Coebergh JW; Rosso S
Eur J Cancer; 2015 Jun; 51(9):1091-8. PubMed ID: 24393522
[TBL] [Abstract][Full Text] [Related]
7. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity.
Moberger P; Sköldberg F; Birgisson H
Acta Oncol; 2018 Dec; 57(12):1611-1621. PubMed ID: 30477372
[TBL] [Abstract][Full Text] [Related]
9. The completeness and timeliness of cancer registration and the implications for measuring cancer burden.
Donnelly C; Cairnduff V; Chen JJ; Kearney T; Fitzpatrick D; Fox C; Gavin A
Cancer Epidemiol; 2017 Aug; 49():101-107. PubMed ID: 28600946
[TBL] [Abstract][Full Text] [Related]
10. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness.
Larsen IK; Småstuen M; Johannesen TB; Langmark F; Parkin DM; Bray F; Møller B
Eur J Cancer; 2009 May; 45(7):1218-1231. PubMed ID: 19091545
[TBL] [Abstract][Full Text] [Related]
11. Estimating Completeness of Cancer Registration in Iran with Capture-Recapture Methods.
Mohammadi G; Akbari ME; Mehrabi Y; Ghanbari Motlagh A; Partovi Pour E; Roshandel G; Khosravi A
Asian Pac J Cancer Prev; 2016; 17(S3):93-9. PubMed ID: 27165215
[TBL] [Abstract][Full Text] [Related]
12. Using Israel's National Cancer Registry Database to Track Progress in the War against Cancer: A Challenge for Health Services.
Robinson E; Silverman BG; Keinan-Boker L
Isr Med Assoc J; 2017 Apr; 19(4):221-224. PubMed ID: 28480674
[TBL] [Abstract][Full Text] [Related]
13. Completeness of a newly implemented general cancer registry in northern France: Application of a three-source capture-recapture method.
Plouvier SD; Bernillon P; Ligier K; Theis D; Miquel PH; Pasquier D; Rivest LP
Rev Epidemiol Sante Publique; 2019 Jul; 67(4):239-245. PubMed ID: 31146902
[TBL] [Abstract][Full Text] [Related]
14. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Dimitrova N; Parkin DM
Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
[TBL] [Abstract][Full Text] [Related]
15. Study of completeness of registration at the Estonian cancer registry.
Lang K; Mägi M; Aareleid T
Eur J Cancer Prev; 2003 Apr; 12(2):153-6. PubMed ID: 12671539
[TBL] [Abstract][Full Text] [Related]
16. Data quality at the Singapore Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Fung JW; Lim SB; Zheng H; Ho WY; Lee BG; Chow KY; Lee HP
Cancer Epidemiol; 2016 Aug; 43():76-86. PubMed ID: 27399312
[TBL] [Abstract][Full Text] [Related]
17. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours.
Leinonen MK; Miettinen J; Heikkinen S; Pitkäniemi J; Malila N
Eur J Cancer; 2017 May; 77():31-39. PubMed ID: 28350996
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015.
Keinan-Boker L; Friedman E; Silverman BG
Cancer Epidemiol; 2018 Oct; 56():6-13. PubMed ID: 30015055
[TBL] [Abstract][Full Text] [Related]
19. Role of outpatient physicians in reporting of hematopoietic malignancies for statewide surveillance.
Lai SM; Keighley J; Garimella S
J Registry Manag; 2014; 41(3):139-45. PubMed ID: 25419608
[TBL] [Abstract][Full Text] [Related]
20. Childhood cancer registration in New Zealand: A registry collaboration to assess and improve data quality.
Ballantine KR; Hanna S; Macfarlane S; Bradbeer P; Teague L; Hunter S; Cross S; Skeen J
Cancer Epidemiol; 2018 Aug; 55():104-109. PubMed ID: 29902672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
